Author

Alison Elizabeth Smith

Kura Oncology (United States)ORCID 0000-0003-2385-1011Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:mouse· 1 Research Focus:perturbation response prediction· 1

Frequent Co-Authors

Amitava MitraiD· 1 shared Ayuna JombikiD· 1 shared Francis J. BurrowsiD· 1 shared Hetika Vora PateliD· 1 shared John Edward GreeriD· 1 shared Jovylyn Gatchalian GasendoiD· 1 shared Linda V. KessleriD· 1 shared Shivani MalikiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Amitava MitraORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

The farnesyl transferase inhibitor KO-2806 re-sensitizes relapsing tumors to RAS inhibition

Hetika Vora Patel, Alison Elizabeth Smith, Stacia Chan, Jovylyn Gatchalian Gasendo, Ayuna Jombik, John Edward Greer, Tejas Samantaray, Linda V. Kessler, Amitava Mitra, Xuefeng Zhu, Yahu A. Liu, Francis J. Burrows, Shivani Malik

This paper identifies mTORC1 activity as a driver of resistance to RAS inhibitors and shows that KO-2806 re-sensitizes resistant tumors to RAS inhibition.

Cancer Research · Feb 9, 2026Peer-reviewedCancer Biology